CPM
Overview
CPM encodes carboxypeptidase M, a membrane-bound metallocarboxypeptidase. In the context of cancer genomics, CPM has been observed as a focal amplification target in glioblastoma multiforme (GBM).
Alterations observed in the corpus
- Recurrent focal amplification in GBM PMID:24120142
Cancer types (linked)
- GBM: focal amplification observed in TCGA GBM cohort PMID:24120142
Co-occurrence and mutual exclusivity
- No co-occurrence or mutual exclusivity data reported in the current corpus.
Therapeutic relevance
- No drug targeting data reported in the current corpus.
Open questions
- Functional role of CPM amplification in GBM pathogenesis is not characterized in the current corpus.
Sources
This page was processed by crosslinker on 2026-05-09.